Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to evaluate the therapeutic equivalence, based on pharmacodynamic parameters of Propofol 2% (20 mg/mL) MCT Fresenius and Diprivan® 20 mg/mL (AstraZeneca), administered by target controlled infusion (TCI).
Critère d'inclusion
- General Anesthesia ,elective surgery